347 related articles for article (PubMed ID: 38673842)
1. Precision Medicine Approaches in Acute Myeloid Leukemia with Adverse Genetics.
Santoro N; Salutari P; Di Ianni M; Marra A
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673842
[TBL] [Abstract][Full Text] [Related]
2. Precision therapy for acute myeloid leukemia.
Yang X; Wang J
J Hematol Oncol; 2018 Jan; 11(1):3. PubMed ID: 29301553
[TBL] [Abstract][Full Text] [Related]
3. Cutting Edge Molecular Therapy for Acute Myeloid Leukemia.
Miyamoto K; Minami Y
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698349
[TBL] [Abstract][Full Text] [Related]
4. Recent advances of targeted therapy in relapsed/refractory acute myeloid leukemia.
Ma J; Ge Z
Bosn J Basic Med Sci; 2021 Aug; 21(4):409-421. PubMed ID: 33577442
[TBL] [Abstract][Full Text] [Related]
5. Advances in acute myeloid leukemia.
Newell LF; Cook RJ
BMJ; 2021 Oct; 375():n2026. PubMed ID: 34615640
[TBL] [Abstract][Full Text] [Related]
6. The Changing Landscape of Treatment in Acute Myeloid Leukemia.
Koenig K; Mims A; Levis MJ; Horowitz MM
Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-12. PubMed ID: 32239961
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive review of genetic alterations and molecular targeted therapies for the implementation of personalized medicine in acute myeloid leukemia.
Kirtonia A; Pandya G; Sethi G; Pandey AK; Das BC; Garg M
J Mol Med (Berl); 2020 Aug; 98(8):1069-1091. PubMed ID: 32620999
[TBL] [Abstract][Full Text] [Related]
8. Precision medicine in acute myeloid leukemia: where are we now and what does the future hold?
Megías-Vericat JE; Martínez-Cuadrón D; Solana-Altabella A; Montesinos P
Expert Rev Hematol; 2020 Oct; 13(10):1057-1065. PubMed ID: 32869672
[TBL] [Abstract][Full Text] [Related]
9. Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine.
Casado P; Cutillas PR
Mol Cell Proteomics; 2023 Apr; 22(4):100517. PubMed ID: 36805445
[TBL] [Abstract][Full Text] [Related]
10. Molecular Changes During Acute Myeloid Leukemia (AML) Evolution and Identification of Novel Treatment Strategies Through Molecular Stratification.
Karjalainen E; Repasky GA
Prog Mol Biol Transl Sci; 2016; 144():383-436. PubMed ID: 27865463
[TBL] [Abstract][Full Text] [Related]
11. Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy.
Conneely SE; Stevens AM
Curr Oncol Rep; 2021 Jan; 23(2):16. PubMed ID: 33439382
[TBL] [Abstract][Full Text] [Related]
12. Acute Myeloid Leukemia: Changing Treatment Paradigms and Novel Agents in Development.
Konig H; Zeidner JF
Curr Cancer Drug Targets; 2020; 20(7):471-472. PubMed ID: 32703130
[No Abstract] [Full Text] [Related]
13. Moving toward targeted therapies in acute myeloid leukemia.
Gao W; Estey E
Clin Adv Hematol Oncol; 2015 Nov; 13(11):748-54. PubMed ID: 27058701
[TBL] [Abstract][Full Text] [Related]
14. A precision medicine approach to management of acute myeloid leukemia in older adults.
Upadhyay Banskota S; Khanal N; Bhatt VR
Curr Opin Oncol; 2020 Nov; 32(6):650-655. PubMed ID: 32826488
[TBL] [Abstract][Full Text] [Related]
15. Prognostic Significance of Molecular Markers and Targeted Regimens in the Management of Acute Myeloid Leukemia.
Tallman M
J Natl Compr Canc Netw; 2018 May; 16(5S):656-659. PubMed ID: 29784749
[TBL] [Abstract][Full Text] [Related]
16. Harnessing the Immune System Against Leukemia: Monoclonal Antibodies and Checkpoint Strategies for AML.
Masarova L; Kantarjian H; Garcia-Mannero G; Ravandi F; Sharma P; Daver N
Adv Exp Med Biol; 2017; 995():73-95. PubMed ID: 28321813
[TBL] [Abstract][Full Text] [Related]
17. A precision medicine classification for treatment of acute myeloid leukemia in older patients.
Mims AS; Kohlschmidt J; Borate U; Blachly JS; Orwick S; Eisfeld AK; Papaioannou D; Nicolet D; Mrόzek K; Stein E; Bhatnagar B; Stone RM; Kolitz JE; Wang ES; Powell BL; Burd A; Levine RL; Druker BJ; Bloomfield CD; Byrd JC
J Hematol Oncol; 2021 Jun; 14(1):96. PubMed ID: 34162404
[TBL] [Abstract][Full Text] [Related]
18. Towards precision medicine for AML.
Döhner H; Wei AH; Löwenberg B
Nat Rev Clin Oncol; 2021 Sep; 18(9):577-590. PubMed ID: 34006997
[TBL] [Abstract][Full Text] [Related]
19. A concise review on the molecular genetics of acute myeloid leukemia.
Padmakumar D; Chandraprabha VR; Gopinath P; Vimala Devi ART; Anitha GRJ; Sreelatha MM; Padmakumar A; Sreedharan H
Leuk Res; 2021 Dec; 111():106727. PubMed ID: 34700049
[TBL] [Abstract][Full Text] [Related]
20. GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia.
Venditti A; Piciocchi A; Candoni A; Melillo L; Calafiore V; Cairoli R; de Fabritiis P; Storti G; Salutari P; Lanza F; Martinelli G; Luppi M; Mazza P; Martelli MP; Cuneo A; Albano F; Fabbiano F; Tafuri A; Chierichini A; Tieghi A; Fracchiolla NS; Capelli D; Foà R; Alati C; La Sala E; Fazi P; Vignetti M; Maurillo L; Buccisano F; Del Principe MI; Irno-Consalvo M; Ottone T; Lavorgna S; Voso MT; Lo-Coco F; Arcese W; Amadori S
Blood; 2019 Sep; 134(12):935-945. PubMed ID: 31395600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]